Cargando…

mTOR: A Potential Therapeutic Target in Osteoarthritis?

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive loss of articular cartilage, remodeling of the subchondral bone, and synovial inflammation. Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that controls critical cellular processes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pal, Bandna, Endisha, Helal, Zhang, Yue, Kapoor, Mohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359178/ https://www.ncbi.nlm.nih.gov/pubmed/25688060 http://dx.doi.org/10.1007/s40268-015-0082-z

Ejemplares similares

PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage
por: Vasheghani, Faezeh, et al.
Publicado: (2015)

mTOR Signaling and Potential Therapeutic Targeting in Meningioma
por: Pinker, Benjamin, et al.
Publicado: (2022)

mTOR pathway – a potential therapeutic target in stroke
por: Melanis, Konstantinos, et al.
Publicado: (2023)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
por: Zhang, Fen, et al.
Publicado: (2023)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
por: Popova, Nadezhda V., et al.
Publicado: (2021)

mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases
por: Wang, Yipin, et al.
Publicado: (2022)

Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
por: Evangelisti, Camilla, et al.
Publicado: (2018)

Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
por: Karagianni, Fani, et al.
Publicado: (2022)

mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
por: Feng, Jiayao, et al.
Publicado: (2022)

Protease-Activatable Porphyrin Molecular Beacon for Osteoarthritis Management
por: Walsh, Connor, et al.
Publicado: (2023)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
por: Babicheva, Aleksandra, et al.
Publicado: (2021)

Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
por: Singh, Shilpi, et al.
Publicado: (2023)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss
por: Cortada, Maurizio, et al.
Publicado: (2021)

Nanotechnology-Based Targeting of mTOR Signaling in Cancer
por: Yoon, Mee-Sup
Publicado: (2020)

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
por: Magaway, Cedric, et al.
Publicado: (2019)

High-fat diet-induced acceleration of osteoarthritis is associated with a distinct and sustained plasma metabolite signature
por: Datta, Poulami, et al.
Publicado: (2017)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021)

The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration
por: Heras-Sandoval, David, et al.
Publicado: (2011)

Effect of autotaxin inhibition in a surgically-induced mouse model of osteoarthritis
por: Datta, Poulami, et al.
Publicado: (2020)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022)

NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
por: Indini, Alice, et al.
Publicado: (2022)

The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials
por: Malley, Cian O., et al.
Publicado: (2015)

Overview of Research into mTOR Inhibitors
por: Mao, Beibei, et al.
Publicado: (2022)

Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
por: AlQurashi, Naif, et al.
Publicado: (2013)

Impact of genetic alterations on mTOR-targeted cancer therapy
por: Sun, Shi-Yong
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f9ainutuqht8g5gaqdkbm20pvl